Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorCingi, Cemal
dc.contributor.authorYorgancıoğlu, Arzu
dc.contributor.authorCingi, Can Cemal
dc.contributor.authorOğuzulgen, Kıvılcım
dc.contributor.authorMuluk, Nuray Bayar
dc.contributor.authorUlusoy, Seçkin
dc.contributor.authorÜnlü, Halis
dc.date.accessioned2019-10-20T21:13:21Z
dc.date.available2019-10-20T21:13:21Z
dc.date.issued2015
dc.identifier.issn2042-6976
dc.identifier.issn2042-6984
dc.identifier.urihttps://dx.doi.org/10.1002/alr.21468
dc.identifier.urihttps://hdl.handle.net/11421/19286
dc.descriptionWOS: 000355860600005en_US
dc.descriptionPubMed ID: 25856270en_US
dc.description.abstractBackgroundIn this prospective, multicenter, randomized, controlled, double-blind study, we investigated the impact of a mobile patient engagement application on health outcomes and quality of life in allergic rhinitis (AR) and asthma patients. MethodsIn total, 327 patients with diagnoses of persistent AR or mild-to-severe persistent asthma were randomized into 2 intervention groups and 2 control groups upon their admission at outpatient clinics. The intervention groups (POPET-AR and POPET-Asthma) received a mobile phone application (physician on call patient engagement trial [POPET]), enabling them to communicate with their physician, and record their health status and medication compliance. The AR groups completed the Rhinitis Quality of Life Questionnaire (RQLQ) at initiation and at the first month of the study. The asthma groups completed the Asthma Control Test (ACT) at initiation and at the third month of the study. ResultsThe POPET-AR group showed better clinical improvement than the control group in terms of the overall RQLQ score as well in measures of general problems, activity, symptoms other than nose/eye, and emotion domains (p < 0.05). In the POPET-Asthma group, more patients (49%) achieved a well-controlled asthma score (ACT > 19) compared with the control group (27%); this was statistically significant (p < 0.05). ConclusionUse of a mobile engagement platform, such as POPET, can have a significant impact on health outcomes and quality of life in both AR and asthma, potentially decreasing the number of hospital admissions, repeat doctor visits, and losses in productivity. Improvements were seen in domains related to activity, productivity, perception of disease, and emotionen_US
dc.description.sponsorshipContinuous Education and Scientific Research Associationen_US
dc.description.sponsorshipWith exception of data collection, preparation of this paper including design and planning was supported by Continuous Education and Scientific Research Association. There was no funding source. There was only scientific support.en_US
dc.language.isoengen_US
dc.publisherWiley-Blackwellen_US
dc.relation.isversionof10.1002/alr.21468en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMobile Healthen_US
dc.subjectMobile Applicationsen_US
dc.subjectPatient Engagementen_US
dc.subjectMedicine Remindersen_US
dc.subjectPatient Communicationen_US
dc.subjectRhinitis Quality Of Life Questionnaire (Rqlq)en_US
dc.subjectAsthma Control Test (Act)en_US
dc.subjectPhysician On Call Patient Engagement Trial (Popet)en_US
dc.subjectAllergic Rhinitis (Ar)en_US
dc.subjectAsthmaen_US
dc.titleThe "physician on call patient engagement trial" (POPET): measuring the impact of a mobile patient engagement application on health outcomes and quality of life in allergic rhinitis and asthma patientsen_US
dc.typearticleen_US
dc.relation.journalInternational Forum of Allergy & Rhinologyen_US
dc.contributor.departmentAnadolu Üniversitesi, İletişim Bilimleri Fakültesien_US
dc.identifier.volume5en_US
dc.identifier.issue6en_US
dc.identifier.startpage487en_US
dc.identifier.endpage497en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US]


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster